Treatment Strategy for Elderly Patients with Soft Tissue Sarcoma

被引:0
作者
Tomoki Nakamura
Akihiro Sudo
机构
[1] Mie University Graduate School of Medicine,Department of Orthopaedic Surgery
来源
Current Oncology Reports | 2022年 / 24卷
关键词
Elderly; Soft tissue sarcoma; Geriatric assessment; Chemotherapy; Surgery; American Society of Anesthesiologists Physical Status;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:563 / 571
页数:8
相关论文
共 251 条
[1]  
Stamenovic D(2021)Pulmonary metastasectomy in soft tissue sarcomas: a systematic review J Thorac Dis 13 2649-2660
[2]  
Hohenberger P(2017)Impact of tumor volume doubling time on post-metastatic survival in bone and soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung Onco Targets Ther 10 559-564
[3]  
Roessner E(2017)Survival and prognostic factors following pulmonary metasatsectomy for sarcoma J Thorac Dis 9 S1305-S1315
[4]  
Nakamura T(2009)Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas Cancer 115 3774-3781
[5]  
Matsumine A(2014)Outcome after radiofrequency ablation of sarcoma lung metastases Cardiovasc Intervent Radiol 37 147-153
[6]  
Takao M(2017)Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial Lancet Oncol 18 1397-1410
[7]  
Nakatsuka A(2012)Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomized, double-blind, placebo-controlled phase 3 trial Lancet 379 1879-1886
[8]  
Matsubara T(2016)Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicenter, phase 3 trial Lancet 387 1629-1637
[9]  
Asanuma K(2008)Significant clinical benefit of fist-line palliative chemotherapy in advanced soft-tissue sarcoma Cancer 112 1585-1591
[10]  
Sudo A(2015)Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase iii randomized multicenter clinical trial J Clin Oncol 34 786-793